Conaghan PG, Bowes MA, Kingsbury SR, et al. Miv-711, a Novel Cathepsin K Inhibitor Demonstrates Evidence of Osteoarthritis Structure Modification: Results from a 6 Month Randomized Double-Blind Placebo-Controlled Phase IIA Trial. ACR 2017, abstract 14L.
Lage versus hoge dosis GC plus rituximab bij ANCA-vasculitis: resultaten na 2 jaar
jan 2024